Clinical Trials Results - National Cancer Institute

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

In English \| En español
Search

NCI Home

Cancer Topics


	Clinical Trials Search Results

Page Options

E-Mail This Search

Clinical Trial Questions?

Get Help:

1-800-4-CANCER or

LiveHelp online chat

	Quick Links


	Help Using the NCI Clinical Trials Search Form Educational Materials About Clinical Trials About NCI's Cancer Clinical Trials Registry Dictionary of Cancer Terms NCI Drug Dictionary

View Content for:

Patients
Health Professionals

Display:

Title
Description with: Locations Eligibility
Full Trial Description
Custom

Results 1-25 of 40 for your search:

Drug:  FOLFOX regimen
Find trials that include:  Any drugs shown
Trial Status:  Closed

Hide Search Criteria

Show Search Criteria

Help with Results

Select All on Page Sort by: Show Results per Page

Phase II/III Randomized Study of Fluorouracil/Leucovorin with vs without Oxaliplatin for Inoperable Metastatic Colorectal Cancer (Summary Last Modified 03/98)

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: FRE-DEB95-OXA-01, EU-96023

Phase III Randomized Study of Leucovorin Calcium Plus Fluorouracil With Either Irinotecan or Oxaliplatin in Patients With Recurrent Metastatic Colorectal Cancer (Summary Last Modified 05/2000)

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: FRE-GERCOR-C97-3/CPTF308, FRE-C97-3/CPTF301, FRE-C97-3/CPTF308, RP-FRE-C97-3/CPTF308, EU-97044, NCT00003260

Phase III Randomized Study of Chronomodulated Versus Nonchronomodulated Administration of Fluorouracil, Leucovorin Calcium, and Oxaliplatin as First Line Treatment in Patients With Locoregionally Recurrent or Metastatic Colorectal Cancer

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18-75
Sponsor:
Protocol IDs: EORTC-05963, NCT00003287

Phase III Randomized Study of Combinations of Oxaliplatin, Fluorouracil, Leucovorin Calcium, and Irinotecan as Initial Therapy in Patients With Advanced Adenocarcinoma of the Colon and Rectum

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-N9741, CAN-NCIC-CO13, CLB-89804, E-N9741, SWOG-N9741, N9741, NCT00003594, CO13

Phase III Study of Fluorouracil and Leucovorin Calcium With or Without Oxaliplatin in Patients With Stage II or III Carcinoma of the Colon

Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: NCI
Protocol IDs: NSABP-C-07, NCT00004931

Phase III Randomized Study of Irinotecan Versus Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Patients With Advanced Colorectal Cancer Previously Treated With Fluorouracil

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-N9841, ECOG-N9841, SWOG-N9841, NCT00005036, N9841

Phase III Randomized Study of Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Patients With Metastatic Colorectal Cancer

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 80
Sponsor: Other
Protocol IDs: FRE-GERCOR-OPTIMOX-2000, EU-20034, NCT00006468

Phase III Study of Surgery With or Without Neoadjuvant and Adjuvant Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Patients With Resectable Colorectal Liver Metastases

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 80
Sponsor: Other
Protocol IDs: EORTC-40983, AGITG-EORTC-40983, ALM-CAO-EORTC-40983, CRUK-LON-EORTC-40983, FFCD-EORTC-40983, EU-20048, CRC-EORTC-40983, NCT00006479

Phase III Randomized Study of Fluorouracil With Leucovorin Calcium and Either Irinotecan or Oxaliplatin in Patients With Unresectable Metastatic Colorectal Cancer

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: MRC-CR08-FOCUS, EU-20038, ISRCTN79877428, NCT00008060

10.

Phase III Randomized Study of Fluorouracil and Leucovorin Calcium Versus Oxaliplatin Alone Versus Fluorouracil, Leucovorin Calcium, and Oxaliplatin in Patients With Metastatic Colorectal Carcinoma (Summary Last Modified 04/2002)

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SANOFI-EFC4584, BRCC-00036, NCT00008281

11.

Phase III Randomized Study of Oxaliplatin, Fluorouracil, and Leucovorin Calcium With or Without Bevacizumab Versus Bevacizumab Only in Patients With Previously Treated Advanced or Metastatic Colorectal Adenocarcinoma

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-3200, NCT00025337, E3200

12.

Phase III Randomized Study of Operative Debulking and Systemic Chemotherapy With or Without Intra- and Peri-Operative Intraperitoneal Chemotherapy in Patients With Peritoneal Carcinomatosis From Low-Grade Gastrointestinal Adenocarcinoma

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-03-C-0085, NCT00056108

13.

Phase III Randomized Study of Oxaliplatin, Fluorouracil, and Leucovorin Calcium With or Without PTK787/ZK 222584 in Patients With Refractory or Recurrent Metastatic Adenocarcinoma of the Colon or Rectum

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0304011, NOVARTIS-CPTK787-0133/304946, NCT00068679

14.

Phase III Randomized Study of Adjuvant Irinotecan, Fluorouracil, and Leucovorin Calcium Versus Oxaliplatin, Fluorouracil, and Leucovorin Calcium Versus Fluorouracil and Leucovorin Calcium in Patients With Stage II or III Rectal Cancer Receiving Combined Radiotherapy and Fluorouracil Either Preoperatively or Postoperatively

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: ECOG-E3201, E3201, NCT00068692

15.

Phase III Randomized Study of Fluorouracil, Leucovorin Calcium, Oxaliplatin, and Bevacizumab Versus Capecitabine, Oxaliplatin, and Bevacizumab in Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-S0303, S0303, ECOG-S0303, NCT00070122

16.

Phase III Randomized Study of Fluorouracil and Leucovorin Calcium With Irinotecan or Oxaliplatin and With or Without Cetuximab in Patients With Previously Untreated Metastatic Adenocarcinoma of the Colon or Rectum

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CALGB-80203, NCT00077233

17.

A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NO16966, NCT00069095

18.

Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CA225014, NCT00061815

19.

Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CPTK787 0135/306241, CONFIRM 1, NCT00056459

20.

Phase III Randomized Study of Adjuvant Chemotherapy Comprising Fluorouracil, Leucovorin Calcium, and Oxaliplatin With Versus Without Bevacizumab in Patients With Resected Stage II or III Adenocarcinoma of the Colon

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NSABP-C-08, NCT00096278

21.

Phase III Randomized Study of Adjuvant Oxaliplatin, Leucovorin Calcium, and Fluorouracil (FOLFOX-4) Versus Bevacizumab and FOLFOX-4 Versus Bevacizumab, Oxaliplatin, and Capecitabine in Patients With High-Risk Stage II or Stage III Colon Cancer

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0412086-01, ROCHE-BO17920A, NCT00112918

22.

Phase II Study of Fluorouracil, Leucovorin, and Oxaliplatin for Colorectal Cancer Resistant to Fluorouracil and Leucovorin Alone (Summary Last Modified 03/98)

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: FRE-FOLFOX-3-4, EU-96022

23.

Phase II Study of Oxaliplatin and Fluorouracil Plus Leucovorin Calcium in Patients with Unresectable Metastatic Adenocarcinoma of the Colon or Rectum

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-974651, NCCTG-97-46-51, NCT00003834

24.

Phase II Pilot Study of Oxaliplatin Combined with Fluorouracil and Leucovorin Calcium in Patients with Advanced Adenocarcinoma of the Colon or Rectum

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: NYU-9863, SANOFI-EFC7132, NCI-G99-1593, NCT00004102

25.

Phase II Study of Oxaliplatin in Combination With Fluorouracil and Leucovorin Calcium in Patients With Recurrent or Metastatic Carcinoma of the Esophagus or Gastric Cardia

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-10015, NCI-T99-0010, NCT00004127, T99-0010

Select All on Page

Help with Results

A Service of the National Cancer Institute